Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding

Drugs Made In America Acquisition II Corp. (NASDAQ: DMII) has entered into an agreement for up to $1.4 million in convertible note funding with Alpha Multi Family Office. The initial tranche involved an unsecured, zero-interest Bridge Note for $150,000, convertible at a 35% discount after the business combination. The funds will be used for accounting, audit, and other expenses related to the company’s business combination.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin